Cost-effectiveness analysis of Japanese Encephalitis (JE) vaccination program in Bali Province, Indonesia.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
13 11 2023
Historique:
received: 15 07 2023
revised: 02 10 2023
accepted: 03 10 2023
medline: 3 11 2023
pubmed: 23 10 2023
entrez: 22 10 2023
Statut: ppublish

Résumé

The incidence of Japanese Encephalitis (JE) in Bali Province remains high, and is one among the highest in Indonesia. The Indonesian Government initiated the JE vaccination campaign followed by a JE vaccine introduction program in Bali Province in 2018. The JE vaccination program then has been fully integrated into the provincial routine immunization program since 2019. We conducted a retrospective economic analysis of JE vaccination program in Bali Province, Indonesia; considering multiple vaccination strategies. We conducted a cost-effectiveness analysis using a decision analytic model comparing two vaccination strategies with no vaccination from the societal and government perspectives. These vaccination strategies were: (1) JE vaccination campaign and introduction program, and (2) a routine JE vaccination program. We compared costs and outcomes for three hypothetical cohorts of 100,000 children followed from birth to the age of 10 years, with impacts measured throughout the child's life-time. We measured the economic consequences as costs per case, per death, and per disability-adjusted life year (DALY) averted. A routine JE immunization program was the most cost-effective strategy with a cost per DALYs averted of US$ 212.59 and US$ 94.09 from the government and societal perspectives respectively. In contrast, costs per DALYs averted through the JE vaccination campaign and introduction strategy was US$ 1,473.53 and US$ 1,224.20 from the government and societal perspectives respectively. Both JE vaccination strategies are cost-effective but they are not cost-saving when compared to no immunization program.

Identifiants

pubmed: 37866992
pii: S0264-410X(23)01177-5
doi: 10.1016/j.vaccine.2023.10.007
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6930-6940

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Anak Agung Sagung Sawitri reports financial support and administrative support were provided by Directorate General Prevention and Control of Disease, Ministry of Health, Republic of Indonesia. Sofya Umi Labiba, Anak Agung Sagung Sawitri reports financial support was provided by GAVI Alliance.

Auteurs

Wayan Citra Wulan Sucipta Putri (WCWS)

Department of Public Health and Preventive Medicine, Faculty of Medicine, Udayana University, Jl. PB Sudirman, Denpasar, Bali 80232, Indonesia. Electronic address: suciptaputri@unud.ac.id.

Anak Agung Sagung Sawitri (AAS)

Department of Public Health and Preventive Medicine, Faculty of Medicine, Udayana University, Jl. PB Sudirman, Denpasar, Bali 80232, Indonesia.

Putu Cintya Denny Yuliyatni (PCD)

Department of Public Health and Preventive Medicine, Faculty of Medicine, Udayana University, Jl. PB Sudirman, Denpasar, Bali 80232, Indonesia.

I Made Dwi Ariawan (IMD)

Department of Public Health and Preventive Medicine, Faculty of Medicine, Udayana University, Jl. PB Sudirman, Denpasar, Bali 80232, Indonesia.

Hashta Meyta (H)

Directorate General Prevention and Control of Disease, Ministry of Health, Jakarta, Indonesia.

Sofya Umi Labiba (SU)

Directorate General Prevention and Control of Disease, Ministry of Health, Jakarta, Indonesia.

I Gusti Ngurah Made Suwarba (IGNM)

Department of Child Health, Faculty of Medicine, Udayana University, Jl. PB Sudirman, Denpasar, Bali 80232, Indonesia.

I Nyoman Sutarsa (IN)

Department of Public Health and Preventive Medicine, Faculty of Medicine, Udayana University, Jl. PB Sudirman, Denpasar, Bali 80232, Indonesia; School of Medicine and Psychology, College of Health and Medicine, The Australian National University, ACT 2001, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH